Blunted cardiovascular growth induction during prolonged nitric oxide synthase blockade.
- 1 September 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 30 (3), 416-421
- https://doi.org/10.1161/01.hyp.30.3.416
Abstract
Abstract The goal of the present study was to characterize the activation profile of the growth-related enzyme ornithine decarboxylase (ODC) in cardiovascular tissue during hypertension induced by chronic NO synthase blockade in relation to the development of structurally based changes in the heart and blood vessels. In previously instrumented conscious rats, mean arterial pressure and ODC activation were measured in cardiovascular tissue of rats treated with N ω -nitro- l -arginine methyl ester (L-NAME; 100 mg/kg per day PO) for 4 hours and 1, 6, and 12 days. After 12 days of L-NAME treatment alone or in combination with 3% L-ornithine, structurally based hindlimb resistance properties were assessed. A marginal activation of ODC in the left ventricle and aorta was seen at 4 hours but returned to control levels at 1, 6, and 12 days of L-NAME treatment. A slightly prolonged yet transient activation of ODC occurred in the mesenteric vascular bed. Structurally based hindlimb vascular resistance was enhanced by 15% at maximum vasoconstrictor tone, and no change in cardiac mass occurred with L-NAME treatment. L-NAME+3% L-ornithine treatment resulted in a similar level of structural upregulation compared with L-NAME treatment alone. In summary, 12 days of L-NAME treatment resulted in only a modest change in vascular resistance, and only at maximum constriction, and no cardiac hypertrophy despite the presence of marked hypertension. The results of the present study indicate that either (1) pressure alone is not a sufficient stimulus to induce cardiovascular growth processes or (2) L-NAME may be “nonspecifically” inhibiting cardiovascular growth processes.Keywords
This publication has 24 references indexed in Scilit:
- No evidence for vascular remodelling during hypertension induced by chronic inhibition of nitric oxide synthase in Brattleboro ratsJournal Of Hypertension, 1995
- Deoxycorticosterone Acetate Plus Salt Induces Overexpression of Vascular Endothelin-1 and Severe Vascular Hypertrophy in Spontaneously Hypertensive RatsHypertension, 1995
- Mechanism of vasoconstriction induced by chronic inhibition of nitric oxide in rats.Hypertension, 1994
- Long-term nitric oxide synthase inhibition and distensibility of carotid artery in intact rats.Hypertension, 1994
- Cardiac weight in hypertension induced by nitric oxide synthase blockade.Hypertension, 1993
- Sodium and angiotensin in hypertension induced by long-term nitric oxide blockade.Hypertension, 1993
- Polyamines, vascular smooth muscle, and deoxycorticosterone acetate-salt hypertension.Hypertension, 1991
- Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism.Hypertension, 1991
- Enalapril can prevent vascular amplifier development in spontaneously hypertensive rats.Hypertension, 1990
- Modulation of arterial smooth muscle cells from contractile to synthetic phenotype requires induction of ornithine decarboxylase activity and polyamine synthesisExperimental Cell Research, 1987